The Conspiracy Against Lithium - Book Review

Author: Michael Nehls, MD, PhD
Title: The Conspiracy Against Lithium: The Suppressed Essential Nutrient and its Benefits for Mental Health
Publication Date: November 18, 2025
Publisher: Skyhorse Publishing

Overview

Dr. Michael Nehls’ The Conspiracy Against Lithium presents a bold thesis: that lithium—a trace element best known in psychiatry as a high‑dose mood stabilizer—is actually an essential nutrient for human mental well‑being and overall neurological balance. Nehls argues that modern diets are deficient in this element, and that this deficiency underlies a wide range of contemporary mental health problems, from depression and suicide to aggression and cognitive decline.

Framing lithium deficiency as a hidden epidemic, Nehls posits what he calls “mental immune deficiency syndrome,” linking inadequate lithium intake to rising rates of anxiety, violence, neurodegeneration, and societal dysfunction.

Key Themes & Arguments

Lithium as an Essential Trace Element

At the heart of Nehls’ argument is the claim that lithium functions in human biology more like an essential micronutrient (like iron or iodine) than strictly a psychiatric drug. According to his presentation, lapses in dietary lithium intake contribute to emotional instability and long‑term cognitive issues.

While mainstream medicine does not yet recognize lithium formally as a required nutrient, a substantial body of epidemiological research shows intriguing associations between extremely low (trace) lithium levels in the environment and mental health outcomes.

Corroborating Scientific Evidence

Here’s how existing research intersects with—or diverges from—Nehls’ thesis. Importantly, none of the studies below alone proves his broader claims about essentiality, but they do highlight patterns that are relevant to the book’s arguments:

GSK3 (Glycogen Synthase Kinase 3) is a crucial enzyme that regulates numerous cellular processes, including glycogen metabolism, cell cycle, and neuronal function. It plays a pivotal role in the phosphorylation of various proteins involved in cell signaling. Dysregulation of GSK3 is implicated in a wide range of diseases, including neurodegenerative disorders like Alzheimer's disease, where GSK3 contributes to tau protein hyperphosphorylation and the formation of neurofibrillary tangles. Additionally, GSK3 is involved in bipolar disorder, where its aberrant activity may affect mood regulation and neuronal plasticity.

Lithium, a well‑known treatment for mood disorders, uniquely targets GSK3 by inhibiting its activity, which is thought to help stabilize mood and provide neuroprotective effects. Unlike conventional antidepressants or antipsychotic drugs, which primarily focus on neurotransmitter systems like serotonin or dopamine, lithium's GSK3 inhibition directly impacts intracellular signaling pathways that regulate neurogenesis, cellular resilience, and protein synthesis. This makes lithium a distinctive therapeutic agent that not only stabilizes mood but also has potential neuroprotective effects in diseases such as Alzheimer's, Parkinson's, and bipolar disorder, highlighting its broad therapeutic potential beyond psychiatric applications.

Lithium & Suicide Rates

Multiple ecological studies have observed an inverse correlation between trace amounts of lithium in drinking water and suicide rates in general populations. A systematic review and meta‑analysis of ecological data concluded that regions with higher lithium concentrations in public water supplies tended to have lower suicide mortality — although causality is not established.

One of the earliest and widely cited studies from Texas (1970s data) found that counties with higher lithium levels in water had reduced rates of suicide, homicide, and violent crime compared to counties with low or undetectable levels.

Another systematic review of ecological studies supports a protective association between lithium levels and suicide risk, though authors note the limitations of ecological study designs and call for individual‑level research.

Low‑Dose Lithium & Neurological Function

Beyond suicide prevention, research on low‑dose lithium (far below psychiatric doses) suggests potential neuroprotective and cognitive benefits. For example:

• Low‑dose lithium has been discussed in the context of Alzheimer’s dementia and cognitive decline, where some small studies find slower progression or beneficial effects — though larger clinical trials are still needed.
• Low‑dose lithium may exert anti‑inflammatory and antioxidative effects on aging tissues, potentially benefiting cardiovascular and neurological function.

Scientific Debate & Contrasting Findings

Some well‑designed municipal studies have failed to find significant associations between trace lithium levels in water and suicide rates when controlling for confounders, underscoring the complexity and uncertainty of the data.

Thus, there is scientific debate rather than consensus about whether trace lithium intake has measurable public health effects — especially at the microgram levels found naturally in the environment.

Lithium vs. Pharmaceutical Drugs

A major section of Nehls’ book argues that lithium (as a nutrient) cannot be substituted by other psychiatric medications — and that reliance on conventional drugs masks deeper biochemical deficiencies.

How Lithium Differs from Other Psychiatric Medications

✔ Mechanism of Action – Broader Biological Effects:
Lithium’s pharmacology is unique among psychiatric agents. In therapeutic doses, it affects intracellular signaling pathways, neurotrophic factors, and may stabilize neuronal circuits over time — qualities not shared by most antidepressants or antipsychotics.

✔ Anti‑Suicide Effects:
Standard‑dose lithium (prescribed for bipolar disorder and mood disorders) has repeatedly been shown in clinical research to reduce rates of suicide and suicidal behavior more reliably than many other psychiatric drugs. Meta‑analyses confirm lithium’s unique profile in this regard.

✔ Non‑Substitutability:
Most antidepressants or anxiolytics target neurotransmitters like serotonin or GABA, whereas lithium’s actions are broader, affecting second messengers and intracellular processes. This makes it pharmacologically distinct — which is precisely Nehls’ argument about why “replacing” lithium with another drug isn’t straightforward.

However, it’s important to note that this does not prove that lithium in trace, nutritional amounts can replace psychiatric medication — a distinction the scientific literature has not yet firmly drawn. Lithium as a medication and lithium in ultra‑low intake contexts remain separate areas of research.

Conclusion

The Conspiracy Against Lithium is a thought‑provoking exploration of a nutrient that has long been boxed into the realm of high‑dose psychiatric medication. Dr. Nehls wisely draws attention to lithium’s broader biological effects and the intriguing patterns in epidemiological studies. Yet while there are compelling associations between trace lithium exposure and mental health outcomes in scientific literature, the evidence remains inconclusive regarding lithium’s essential nutrient status or its preventive public health application. For curious readers, the book is a call to explore a neglected topic.